ConductScience.org, home

Cell line · CVCL_3798

SV-HUC-1

Transformed cell line, Homo sapiens. 41 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. SV-HUC-1. Cell lines, record CVCL_3798. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_3798

On this page

Cell line

As Cellosaurus gives it.

Name
SV-HUC-1
Accession
CVCL_3798
RRID
RRID:CVCL_3798
Synonyms
HUC-1, SV-HUC, SVHUC
Species
Homo sapiens (Human)
Sex
Male
Age at sampling
11Y
Category
Transformed cell line
Derived from
Ureter (in situ)
Cell type
Epithelial cell
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers41

PaperJournalYearHow we knowRetractedSource
SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis.Transl Androl Urol2026Its Methods give the RRID and name the linePubMed
Biophysical reprogramming of immunosuppressive neutrophils by cold atmospheric plasma reinvigorates antitumor immunity.Sci Adv2026Its Methods give the RRID and name the linePubMed
Reprogramming-driven Proteomic Shifts Mirror Bladder Cancer Progression and Reveal Biomarker Candidates Across Disease Grades.Cancer Genomics Proteomics2026Its Methods give the RRID and name the linePubMed
O-GlcNAcylated TAP1 Impairs Antigen Presentation and Promotes Immune Evasion in Bladder Cancer.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
HSPB6: A Potential Prognostic Biomarker, Inhibiting the Epithelial-Mesenchymal Transition (EMT) Process Through the PI3K/Akt Signaling Pathway Based on the Machine Learning and Experimental Validation.
Hum Mutat2026Its Methods give the RRID and name the linePubMed
A 'two-in-one' tumor-specific-hydrogel-assisted strategy for intravesical chemotherapy and protection of normal tissues.J Nanobiotechnology2026Its Methods give the RRID and name the linePubMed
Proteomic Signatures of Cellular Reprogramming in Bladder Cancer: Insights into the Acquisition of Cancer Stem-like States and Phenotypic Plasticity.Cancer Genomics Proteomics2026Its Methods give the RRID and name the linePubMed
m5C-Modified tRF3b-CysGCA-23 Suppresses Bladder Cancer Malignancy by Repressing H3K18 Lactylation via Stabilizing RBM4.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
FomA-Containing Outer Membrane Vesicles of Fusobacterium Nucleatum Facilitate Bladder Cancer Lymphatic Metastasis via IL-6-Dependent M2b Macrophage Polarization.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Conjoining cell reprogramming and mass spectrometry to identify the proteomic variations in the reprogrammed bladder cancer cells: finding cues of normalisation.BMC Cancer2026Its Methods give the RRID and name the linePubMed

1 to 10 of 41

See all 41 papers

Relatives19

RelationCell lineAccessionProblemSource
Derived from itEDITGENE SV-HUC-1-Cas9CVCL_F5QPCell lines
Derived from itEDITGENE SV-HUC-1-CopGFPCVCL_F5ZJCell lines
Derived from itEDITGENE SV-HUC-1-FLUCCVCL_F5S2Cell lines
Derived from itMC-SV-HUC T-1CVCL_IP86Cell lines
Derived from itMC-SV-HUC T-10CVCL_IP89Cell lines
Derived from itMC-SV-HUC T-11CVCL_IP90Cell lines
Derived from itMC-SV-HUC T-16CVCL_IP91Cell lines
Derived from itMC-SV-HUC T-2CVCL_6418Cell lines
Derived from itMC-SV-HUC T-7CVCL_IP87Cell lines
Derived from itMC-SV-HUC T-9CVCL_IP88Cell lines

Cell banks6

Cell bankCatalog numberStatusSource
ATCCCRL-9520ATCC
BCRC60358BCRC
CLS305075CLS
EDITGENEEDC00197EDITGENE
HysigenTCH-C341Hysigen
KCBKCB 2012112YJCellosaurus

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_3798

GET https://conductscience.org/api/cell-lines/v1/CVCL_3798/papers?page=2